Experience
Buy-side Advice
Transaction advisory to RQM+, a portfolio company of Linden Capital Partners, on the acquisition of CRO Dr. med. Kottmann GmbH & Co. KG
Are you interested in selling your company or acquiring a company?
For information on how we carry out such projects, please visit our website or contact us directly. The Holon team are available to help with any enquiries you may have. Contact us
Company information
RQM+ is the world’s leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+’s global team of clinical, technical, and top industry experts push the boundaries of excellence. With more former FDA, Medicines, and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. We reduce commercialisation risk by offering a full complement of CRO services to progress medical devices, digital therapeutics and diagnostics onto the market and keep them there. In addition to early- and mid-stage MedTech companies, we currently work with 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies.
Target information
CRO Dr. med Kottmann, based in Germany, is a leading Contract Research Organisation (CRO) celebrated for its unmatched customer service and commitment to quality. As an international CRO, Kottmann conducts clinical studies with medical devices, in vitro diagnostics (IVDs) and pharmaceuticals. In addition to full service, Kottmann also offers individual services such as the creation of databases (eCRFs), statistical evaluations and clinical monitoring for your study.